JAK2 and Myocardial fibrosis: Recently, accumulating evidence has indicated that JAK2 phosphorylation is linked to cardiovascular conditions, including atherosclerosis, diabetes mellitus [82], myocardial fibrosis [83], and myocardial ischemia–reperfusion injury [84].